Management of Gastric Tumor Perforation with Conservative Treatment during Neoadjuvant Chemotherapy.
Journal
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
ISSN: 1681-7168
Titre abrégé: J Coll Physicians Surg Pak
Pays: Pakistan
ID NLM: 9606447
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
07
05
2020
accepted:
28
11
2020
entrez:
5
1
2022
pubmed:
6
1
2022
medline:
7
1
2022
Statut:
ppublish
Résumé
Perioperative chemotherapy provides advantage for gastric cancer patients in terms of survival. A 56-year male with a diagnosis of locally advanced gastric carcinoma presented with complaints of acute abdominal pain; and was diagnosed as gastric tumor perforation during neoadjuvant therapy. Gastric perforation may occur during neoadjuvant chemotherapy for gastric cancer. While the treatment of choice for these perforations was surgery in the past, it is now shifting towards a minimally invasive or non-invasive approach. We used the minimally invasive treatment approach with nasogastric drainage, intravenous antibiotics and proton pump inhibitors, which was effective in the treatment of perforation. Althrough, conservative treatment approach may be an effective management option in selected patients with gastric cancer perforation. Key Words: Gastric cancer, Neoadjuvant chemotherapy, Perforation.
Identifiants
pubmed: 34983163
pii: 040579197
doi: 10.29271/jcpsp.2022.01.117
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM